BB Biotech AG (BBZA.DE)
EUR 39.05
(0.77%)
EUR 39.05
(0.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | -199.56 Million | -351.22 Million | -396.22 Million | 699.23 Million | 685.23 Million | -465.75 Million |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | -199.56 Million | -351.22 Million | -396.22 Million | 699.23 Million | 685.23 Million | -465.75 Million |
| Operating Expenses | -199.56 Million | 6.52 Million | 8.52 Million | 7.98 Million | 7.73 Million | 5.51 Million |
| Selling, General and Administrative Expenses | 5.79 Million | 5.43 Million | 7.35 Million | 6.84 Million | 6.52 Million | 4.85 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -205.36 Million | 1.09 Million | 1.16 Million | 1.14 Million | 1.21 Million | 669 Thousand |
| Cost and Expenses | -199.56 Million | 6.52 Million | 8.52 Million | 7.98 Million | 7.73 Million | 5.51 Million |
| Operating Income | -29.92 Million | -356.02 Million | -404.74 Million | 691.24 Million | 677.49 Million | -470.18 Million |
| Interest Expense | 5.8 Million | 1.72 Million | 986 Thousand | 883 Thousand | 1.24 Million | 1.08 Million |
| Income Tax Expense | 79 Thousand | 61 Thousand | 67 Thousand | 75 Thousand | 68 Thousand | 71 Thousand |
| Earnings before Tax | -206.52 Million | -357.75 Million | -404.74 Million | 691.24 Million | 677.49 Million | -471.27 Million |
| Net Income | -206.6 Million | -357.81 Million | -404.8 Million | 691.17 Million | 677.43 Million | -471.34 Million |
| Earnings Per Share Basic | -3.77 | -6.50 | -7.31 | 12.48 | 12.23 | -8.51 |
| Earnings Per Share Diluted | -3.77 | -6.50 | -7.31 | 12.48 | 12.23 | -8.51 |
| Weighted Average Shares Outstanding | 54.84 Million | 55.01 Million | 55.36 Million | 55.39 Million | 55.4 Million | 55.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.84 Million | 55.01 Million | 55.36 Million | 55.39 Million | 55.4 Million | 55.4 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | 1.01 | 1.01 | 1.02 | 0.99 | 0.99 | 1.01 |
| Profit Margin | 1.04 | 1.02 | 1.02 | 0.99 | 0.99 | 1.01 |
| EBITDA | -201.25 Million | -357.28 Million | -402.79 Million | 691.24 Million | 677.49 Million | -429.63 Million |
| Earnings Before Tax Margin | 0.15 | 1.01 | 1.02 | 0.99 | 0.99 | 1.01 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | -79.33 Million | 262.26 Million | 111.17 Million | -199.56 Million | -40.7 Million | -4.67 Million |
| Cost of Revenue | -79.36 Million | -8.44 Million | - | - | - | - |
| Gross Profit | 32 Thousand | 270.7 Million | 111.17 Million | -199.56 Million | -40.7 Million | -4.67 Million |
| Operating Expenses | 7.73 Million | 1.75 Million | 2.01 Million | 6.96 Million | 7.67 Million | 8.78 Million |
| Selling, General and Administrative Expenses | 7.73 Million | 1.68 Million | 1.2 Million | - | 7.67 Million | 8.78 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 85.52 Million | 8.76 Million | 2.01 Million | 6.96 Million | 7.67 Million | 8.78 Million |
| Operating Income | -7.69 Million | 261.96 Million | 109.15 Million | -206.52 Million | -48.37 Million | -13.46 Million |
| Interest Expense | 1.57 Million | 1.43 Million | 1.58 Million | 5.8 Million | 1.66 Million | 1.44 Million |
| Income Tax Expense | 19 Thousand | 19 Thousand | 34 Thousand | 79 Thousand | 15 Thousand | 14 Thousand |
| Earnings before Tax | -87.06 Million | 260.51 Million | 109.15 Million | -206.52 Million | -48.37 Million | -13.46 Million |
| Net Income | -87.08 Million | 260.49 Million | 109.11 Million | -206.6 Million | -48.39 Million | -13.47 Million |
| Earnings Per Share Basic | -1.60 | 4.75 | 1.99 | - | -0.89 | -0.25 |
| Earnings Per Share Diluted | -1.60 | 4.75 | 1.99 | - | -0.89 | -0.24 |
| Weighted Average Shares Outstanding | 54.42 Million | 54.84 Million | 54.84 Million | 54.84 Million | 54.37 Million | 54.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.42 Million | 54.84 Million | 54.84 Million | 54.84 Million | 54.37 Million | 56.15 Million |
| Gross Margin | -0.00 | 1.03 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | 1.00 | -0.01 | 0.98 | - | 1.19 | 2.88 |
| Profit Margin | 1.10 | 0.99 | 0.98 | 1.04 | 1.19 | 2.88 |
| EBITDA | -79.36 Million | -1.45 Million | 109.15 Million | - | -48.37 Million | -13.46 Million |
| Earnings Before Tax Margin | 0.10 | 1.00 | 0.98 | 1.03 | 1.19 | 2.88 |
ALGEV
2871
ENR
002232
1723
COEP